Top Stories

Mankind Board Approves 100% Acquisition of Bharat Serums and Vaccines

Jul 26, 2024

By: BlinkX Research Team

Pharmaceutical company Mankind Pharma announced on Thursday, July 25, that it will acquire the entire stake in Bharat Serums and Vaccines Ltd (BSV) from Advent International for an enterprise value of around ₹13,630 crore.

Key Takeaways from the acquisition

• Mankind Pharma announced it will acquire 100% of Bharat Serums and Vaccines Ltd (BSV) from Advent International.
• The deal is valued at approximately ₹13,630 crore.
• Mankind Pharma aims to expand into complex portfolios and position itself as a market leader in the Indian women's health and fertility segment.

Mankind Pharma is strategically expanding into complex portfolios with high entry barriers, particularly in women's health, fertility, critical care, and the immunoglobulin segment. This move aims to establish the company as a market leader in the Indian women's health and fertility sector, as mentioned in a stock exchange filing.

BSV has been a leader in the biopharmaceuticals' industry for more than 50 years. It has developed recombinant and niche biologic products internally, showcasing its strong R&D capabilities. It also has a robust branded product portfolio in the critical care, fertility, and women's health domains, with a few of its marque brands holding prominent positions in their respective therapy areas.

"BSV's acquisition represents a pivotal milestone in Mankind’s journey, establishing us as the market leader in Indian women’s health & fertility segment. We believe women’s health & fertility segment has massive opportunity along with strong growth visibility globally, led by structural tailwinds."Rajeev Juneja, Vice-chairman and Managing Director of Mankind Pharma, commented on the acquisition.

About Mankind Pharma Ltd

Founded in 1991 and commencing operations in 1995, the company is India's fourth-largest pharmaceutical firm in terms of domestic sales. It is involved in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Operating at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors, the company aims to provide quality products at affordable prices and has a proven track record of building and scaling brands in-house.

Read More About Mankind Pharma Ltd Share Price Here!